Electrochaea
operates commercial-scale biological methanation plants in Denmark and Switzerland; its patented thermophilic Methanothermobacter catalyst converts CO2 and green hydrogen into pipeline-quality biomethane at high selectivity.
- Country
- Germany
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| biofuels-bioenergy | ✓ | ✓ | ✓ |
Regulatorsepareachnea
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Power-to-X with biological step | biofuels-bioenergy | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.